This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aziz, N.
Right arrow Articles by Fahey, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aziz, N.
Right arrow Articles by Fahey, J. L.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 1999, p. 89-95, Vol. 6, No. 1
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Variables That Affect Assays for Plasma Cytokines and Soluble Activation Markers

Najib Aziz,1 Parunag Nishanian,1 Ronald Mitsuyasu,2 Roger Detels,3 and John L. Fahey1,2,*

CIRID at University of California, Los Angeles, Department of Microbiology and Immunology,1 Department of Medicine, the Jonsson Comprehensive Cancer Center, and the UCLA AIDS Institute, UCLA School of Medicine,2 and Department of Epidemiology, UCLA School of Public Health,3 Los Angeles, California 90095

Received 29 June 1998/Returned for modification 25 August 1998/Accepted 12 October 1998

Cytokines and soluble immune activation markers that reflect cytokine activities in vivo are increasingly being measured in plasma, serum, and other body fluids. They provide useful diagnostic and prognostic information as well as insight into disease pathogenesis. Assays of neopterin, beta 2-microglobulin, soluble interleukin-2 receptor, and soluble tumor necrosis factor receptor type II as well as of the cytokines tumor necrosis factor alpha and gamma interferon (IFN-gamma ) were evaluated by using serum and plasma samples of human immunodeficiency virus (HIV)-positive and HIV-negative subjects. Many factors were found to influence the outcomes of these assays. Substantial differences in apparent levels of analytes were frequently found when enzyme-linked immunosorbent assay (ELISA) kits from different manufacturers were used. In some cases, differences were found in the standards provided by separate manufacturers. Furthermore, the analytic results from different lots of ELISA kits supplied by single manufacturers differed by as much as 50%. The need for uniformity in the standards for quantitative assays was clearly illustrated. International reference standards are available for cytokines but not for soluble cytokine receptors or soluble activation markers. Marker levels in serum or in plasma were similar except those for IFN-gamma . Most of the analytes were stable under several storage conditions. Thus, batch testing of frozen stored samples is feasible. The findings indicate that for longitudinal studies, the levels of cytokines and immune activation markers in plasma or serum should be measured by using preverified reagents from one manufacturer. The quality of laboratory performance can have an impact on clinical relevance. Proficiency testing and external quality assurance programs can help to develop the needed consensus.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, CA 90095-1747. Phone: (310) 825-6568. Fax: (310) 206-1318. E-mail: jlfahey{at}ucla.edu.

Clinical and Diagnostic Laboratory Immunology, January 1999, p. 89-95, Vol. 6, No. 1
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Rundle, A. G., Vineis, P., Ahsan, H. (2005). Design Options for Molecular Epidemiology Research within Cohort Studies. Cancer Epidemiol. Biomarkers Prev. 14: 1899-1907 [Abstract] [Full Text]  
  • Morley, J. E., Baumgartner, R. N. (2004). Cytokine-Related Aging Process. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59: M924-M929 [Full Text]  
  • Douglas, S. D., Durako, S., Sullivan, K. E., Camarca, M., Moscicki, A.-B., Wilson, C. M. (2003). TH1 and TH2 Cytokine mRNA and Protein Levels in Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Youths. CVI 10: 399-404 [Abstract] [Full Text]  
  • Bower, J. E., Ganz, P. A., Aziz, N., Fahey, J. L. (2002). Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors. Psychosom. Med. 64: 604-611 [Abstract] [Full Text]  
  • Leader of the Working Group: M.M. Kelly, , Members of the Working Group:, , Keatings, V., Leigh, R., Peterson, C., Shute, J., Venge, P., Djukanovic, R. (2002). Analysis of fluid{-}phase mediators. Eur Respir J 20: 24S-39s [Full Text]  
  • Sullivan, K. E., Cutilli, J., Piliero, L. M., Ghavimi-Alagha, D., Starr, S. E., Campbell, D. E., Douglas, S. D. (2000). Measurement of Cytokine Secretion, Intracellular Protein Expression, and mRNA in Resting and Stimulated Peripheral Blood Mononuclear Cells. CVI 7: 920-924 [Abstract] [Full Text]  
  • Breen, E. C., McDonald, M., Fan, J., Boscardin, J., Fahey, J. L. (2000). Cytokine Gene Expression Occurs More Rapidly in Stimulated Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Persons. CVI 7: 769-773 [Abstract] [Full Text]  
  • Fahey, J. L., Aziz, N., Spritzler, J., Plaeger, S., Nishanian, P., Lathey, J. L., Seigel, J., Landay, A. L., Kilarui, R., Schmitz, J. L., White, C., Wara, D. W., Akridge, R., Cutili, J., Douglas, S. D., Reuben, J., Shearer, W. T., Nokta, M., Polland, R., Schooley, R., Asthana, D., Mizrachi, Y., Waxdal, M. (2000). Need for an External Proficiency Testing Program for Cytokines, Chemokines, and Plasma Markers of Immune Activation. CVI 7: 540-548 [Abstract] [Full Text]  
  • Abuodeh, R. O., Shubitz, L. F., Siegel, E., Snyder, S., Peng, T., Orsborn, K. I., Brummer, E., Stevens, D. A., Galgiani, J. N. (1999). Resistance to Coccidioides immitis in Mice after Immunization with Recombinant Protein or a DNA Vaccine of a Proline-Rich Antigen. Infect. Immun. 67: 2935-2940 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»